January 30, 2018 PR-M01-18-NI-091
PALM BEACH, Florida, January 25, 2018 /PRNewswire/ —
Marketnewsupdates.com News Commentary
Reliq Health Technologies Inc. (OTCQB: RQHTF) (TSX-V: RHT.V), a technology company focused on creating innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, is pleased to announce that it has signed an agreement with True Life Home Health LLC in Texas to provide Reliq's iUGO Care chronic care management, remote patient monitoring and telemedicine platform to their over 2,000 home care clients. This contract will generate over $1,200,000 USD in recurring annual revenue at full deployment. Patient enrolment will begin in February 2018. In total Reliq now has contracts in place to provide its iUGO Care platform to over 50,000 patients, representing over $30 Million USD in recurring annual revenue at full deployment.
"We are very pleased to be working with True Life Home Health to deliver high quality care to patients in the home," said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc. "Reliq's iUGO Care remote patient monitoring system quickly and easily collects sophisticated health data from patients in their own homes. Our secure, cloud-based care collaboration platform provides the clinical care team, patient and family members with real-time access to patient health information including trends over time. This helps the care team identify patients whose condition is becoming unstable and intervene early, before a serious complication develops. Patients and their loved ones are able to clearly see how compliance with prescribed medication and lifestyle changes affect the patient's health status, improving patient engagement and patient- and family-reported satisfaction. The iUGO Care virtual care platform was designed to reduce readmissions and improve health outcomes. Our technology allows patients to receive high quality care from the comfort of their own homes, reducing the cost of care delivery and increasing patient and family satisfaction."
Read this full release and recent news releases for Reliq Health Technologies at: http://marketnewsupdates.com/news/rqhtf.html
"True Life Home Health is committed to providing high quality care to complex chronic disease patients in the comfort of their own homes," said Sonia Anciso, President. "We are excited to be working with Reliq Health to support our care providers in their day-to-day workflow, freeing up more time for patient care. We feel that incorporating cutting edge technologies like the iUGO Care platform will help True Life improve health outcomes and reduce overall healthcare costs."
True Life Home Health is certified by the Centers for Medicare & Medicaid Services (CMS). The company offers in home care from qualified health professionals as well as telemonitoring services to connect patients with their care team from the comfort of their own homes. True Life Home Health's caring and qualified healthcare providers are committed to supporting patients and families who are coping with chronic conditions like Congestive Heart Failure (CHF), Chronic Obstructive Pulmonary Disease (COPD) and Diabetes, recovering at home from surgery or injuries, and seniors who are aging in place.
In other Healthcare Industry developments:
Medical Innovation Holdings Inc. (OTC: MIHI) closed up over 21% on Wednesday at $0.485 after closing up in Tuesday trading as well closing up over 33% for the day of trading. This week the company announced its future development efforts will include blockchain technology. The Company understands today's methods of protecting patient medical and financial data that is continually threatened by 'digital assassins' dedicated to finding weaknesses in systems for the purpose of stealing sensitive data and/or holding companies' hostage for return of data. This environment cannot continue to exist. MIHI sees blockchain, an immutable ledger of information that can be permissioned, shared and trusted, as a key part of the answer to solve these critical weaknesses. The Company recently announced its endeavor into the Health Care Sharing Organizations (HCSO) marketplace and has determined the systems necessary to best capitalize and manage this marketplace will be blockchain centric. The Company expects other faith-based and ethics-based sharing organizations to incorporate the MIHI Blockchain Platform where appropriate security and exchange of data is a requisite to ensure patients, providers and payers are all able to benefit from this technology platform. This will make for a more efficient movement of secure data, resulting in lower transactional costs of moving data across a world-wide network. MIHI plans to release an initial version to support its own operations and then later migrate the application to allow third-party sharing organizations to utilize the platform under a transaction fee arrangement.
As information moves to patient portals that allow universal access to data across disparate medical systems in hospitals, physician offices, insurance companies, and employers, blockchain technology will enable the patient to finally be at the center of their care model and thereby providing them with the best system to provide protection and create trust between elements of their care continuum.
Teladoc Inc. (NYSE: TDOC) closed up slightly on Wednesday at $34.90 trading over 890,000 shares by the market close and was also up very slightly in afterhours trading. The company recently announced the commercial availability of its integrated mobile app experience. Members can now benefit from a single, patient-centered point of access to answers for a wide array of medical needs, as the app combines the high frequency care services traditionally provided by Teladoc, along with the expert specialty medical and second opinion services of Best Doctors. Following the successful limited release to select clients in Q4 2017, the integrated app is now commercially available for all joint Teladoc and Best Doctors current and future clients. "The integrated mobile app is foundational for Teladoc as we have redefined virtual care delivery and are providing our members and their families with a better way to navigate their individual care journey. With an approachable, simple-to-navigate experience and a curated set of services, we are enabling members to get answers to a range of health needs, empowering them to make smarter decisions and ultimately improve their healthcare outcomes," says Dan Trencher, SVP of Product and Strategy for Teladoc.
Tenet Healthcare Corporation (NYSE: THC) closed up slightly on Wednesday at $18.29 trading over 2.3 million shares by the market close. The company recently announced it has completed the sale of its Philadelphia-area acute care hospitals and related operations to American Academic Health System, LLC (AAHS), an affiliate of Paladin Healthcare. Tenet and Paladin Healthcare previously announced the transaction on September 1, 2017. The facilities included in the sale are Hahnemann University Hospital, St. Christopher's Hospital for Children and other hospital-affiliated entities, including physician practices. Tenet received net pre-tax proceeds from the transaction of approximately $152.5 millionin cash and a secured promissory note for $17.5 million.
Community Health Systems Inc. (NYSE: CYH) also closed up slightly on Wednesday at $5.45 trading over 2.2 million shares by the market close. Community Health Systems, Inc. is one of the largest publicly traded hospital companies in the United States and a leading operator of general acute care hospitals in communities across the country. The Company, through its subsidiaries, owns, leases or operates 127 affiliated hospitals in 20 states with an aggregate of approximately 21,000 licensed beds.
DISCLAIMER: MarketNewsUpdates.com (MNU) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. MNU is NOT affiliated in any manner with any company mentioned herein. MNU and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. MNU's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. MNU is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed MNU has been compensated twenty-three hundred dollars for news coverage of the current press release issued by Reliq Health Technologies Inc. by a non-affiliated third party. MNU HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and MNU undertakes no obligation to update such statements.
Tel: +1 561 325 8757
Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.